$OBLG
Oblong, Inc. Stock $oblg

$oblg Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000074621024000009 Filed on March 19, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$626.0K	$944.0K	$3.810M
YoY Change	-39.69%	-33.8%	-30.42%
Cost Of Revenue	$629.0K	$655.0K	$2.899M
YoY Change	-17.45%	-42.04%	-26.23%
Gross Profit	-$3.000K	$289.0K	$911.0K
YoY Change	-101.09%	-2.36%	-41.07%
Gross Profit Margin	-0.48%	30.61%	23.91%
Selling, General & Admin	$1.131M	$1.215M	$5.179M
YoY Change	-18.46%	-15.86%	-22.81%
% of Gross Profit		420.42%	568.5%
Research & Development	$50.00K	$4.000K	$20.00K
YoY Change	733.33%	-93.85%	-98.82%
% of Gross Profit		1.38%	2.2%
Depreciation & Amortization	$0.00	$86.00K	$345.0K
YoY Change	-100.0%	1.18%	-81.87%
% of Gross Profit		29.76%	37.87%
Operating Expenses	$1.181M	$1.305M	$5.544M
YoY Change	-15.22%	-18.13%	-34.06%
Operating Profit	-$1.184M	-$1.016M	-$4.633M
YoY Change	-1.58%	-21.73%	-78.93%
Interest Expense	$0.00	-$2.000K	-$28.00K
YoY Change	-100.0%	-88.89%	47.37%
% of Operating Profit
Other Income/Expense, Net	$48.00K	$46.00K	$166.0K
YoY Change	118.18%	-22.03%	315.0%
Pretax Income	-$1.136M	-$1.232M	-$4.357M
YoY Change	-3.81%	0.0%	-80.15%
Income Tax	$0.00	-$11.00K	$27.00K
% Of Pretax Income
Net Earnings	-$1.136M	-$1.282M	-$5.503M
YoY Change	-6.81%	5.34%	-74.92%
Net Earnings / Revenue	-181.47%	-135.81%	-144.44%
Basic Earnings Per Share	-$0.07		-$0.98
Diluted Earnings Per Share	-$0.07	-$0.09	-$0.98
COMMON SHARES
Basic Shares Outstanding	16.68M shares	14.95M shares	5.595M shares
Diluted Shares Outstanding	17.12M shares		5.595M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.360M	$5.990M	$5.990M
YoY Change	44.32%	94.17%	94.17%
Cash & Equivalents	$5.360M	$5.990M
Short-Term Investments		$500.0K
Other Short-Term Assets	$421.0K	$243.0K	$243.0K
YoY Change	-55.54%	170.0%	-62.56%
Inventory	$127.0K	$239.0K	$239.0K
Prepaid Expenses		$75.00K
Receivables	$15.00K	$424.0K	$424.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.923M	$6.896M	$6.896M
YoY Change	4.15%	41.54%	41.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$17.00K	$17.00K
YoY Change	-100.0%	466.67%	-88.28%
Goodwill
YoY Change
Intangibles	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Investments
YoY Change
Other Assets	$12.00K	$12.00K	$12.00K
YoY Change	-61.29%	-70.0%	-70.0%
Total Long-Term Assets	$12.00K	$29.00K	$29.00K
YoY Change	-98.16%	-96.32%	-96.32%
TOTAL ASSETS
Total Short-Term Assets	$5.923M	$6.896M	$6.896M
Total Long-Term Assets	$12.00K	$29.00K	$29.00K
Total Assets	$5.935M	$6.925M	$6.925M
YoY Change	-6.36%	22.33%	22.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$351.0K	$211.0K	$211.0K
YoY Change	69.57%	14.67%	14.67%
Accrued Expenses	$1.031M	$779.0K	$779.0K
YoY Change	-38.08%	-27.47%	-29.57%
Deferred Revenue	$105.0K	$132.0K
YoY Change	-69.21%	-69.72%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.487M	$1.398M	$1.398M
YoY Change	-36.78%	-26.92%	-26.92%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$14.00K	$26.00K	$26.00K
YoY Change	-83.33%	-80.15%	-80.15%
Total Long-Term Liabilities	$14.00K	$26.00K	$26.00K
YoY Change	-83.33%	-80.15%	-80.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.487M	$1.398M	$1.398M
Total Long-Term Liabilities	$14.00K	$26.00K	$26.00K
Total Liabilities	$1.501M	$1.424M	$1.424M
YoY Change	-38.38%	-30.33%	-30.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$229.4M	-$228.2M
YoY Change	1.91%	1.96%
Common Stock	$234.0M	$233.9M
YoY Change	2.11%	2.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.434M	$5.501M	$5.501M
YoY Change
Total Liabilities & Shareholders Equity	$5.935M	$6.925M	$6.925M
YoY Change	-6.36%	22.33%	22.33%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.136M	-$1.282M	-$5.503M
YoY Change	-6.81%	5.34%	-74.92%
Depreciation, Depletion And Amortization	$0.00	$86.00K	$345.0K
YoY Change	-100.0%	1.18%	-81.87%
Cash From Operating Activities	-$630.0K	-$705.0K	-$2.993M
YoY Change	-25.36%	-33.36%	-49.56%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change			-100.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities		$0.00	$0.00
YoY Change			-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.898M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	-71.00K	5.898M
YoY Change	-100.0%
NET CHANGE
Cash From Operating Activities	-$630.0K	-705.0K	-2.993M
Cash From Investing Activities		0.000	0.000
Cash From Financing Activities	$0.00	-71.00K	5.898M
Net Change In Cash	-$630.0K	-776.0K	2.905M
YoY Change	-200.16%	-26.65%	-149.11%
FREE CASH FLOW
Cash From Operating Activities	-$630.0K	-$705.0K	-$2.993M
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$705.0K	-$2.993M
YoY Change		-33.36%	-49.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35376
CY2023	dei	Entity Registrant Name EntityRegistrantName	OBLONG, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	110 16th Street
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1400-1024
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80202
CY2023	dei	City Area Code CityAreaCode	213
CY2023	dei	Local Phone Number LocalPhoneNumber	683-8863 ext. 5
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2023	dei	Trading Symbol TradingSymbol	OBLG
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	415000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	723000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	649000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	309000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1431000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4870000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5278000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	728000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000746210
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.06667
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0312442
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3002041	usd
CY2023	dei	Auditor Name AuditorName	EisnerAmper LLP
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16684571	shares
CY2023	dei	Auditor Firm AuditorFirmId	274
CY2023	dei	Auditor Location AuditorLocation	Iselin, New Jersey
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5990000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3085000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	239000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	243000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	6896000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4872000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	604000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	142000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	12000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	40000	usd
CY2023Q4	us-gaap	Assets Assets	6925000	usd
CY2022Q4	us-gaap	Assets Assets	5661000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	211000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	184000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1038000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1074000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	132000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	436000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	219000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1398000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1913000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	26000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	114000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	26000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	131000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1424000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2044000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16692000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16685000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2071000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2063000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	8000	shares
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	181000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	181000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	233911000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	227645000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-228231000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-223847000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5501000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3617000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6925000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5661000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3810000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5476000	usd
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	2899000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3930000	usd
CY2023	us-gaap	Gross Profit GrossProfit	911000	usd
CY2022	us-gaap	Gross Profit GrossProfit	1546000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1699000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	262000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12740000	usd
CY2023	glow	Inventory Write Down Net Of Insurance Proceeds InventoryWriteDownNetOfInsuranceProceeds	-400000	usd
CY2022	glow	Inventory Write Down Net Of Insurance Proceeds InventoryWriteDownNetOfInsuranceProceeds	483000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	345000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1903000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	5406000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	23534000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4495000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-21988000	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	28000	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	19000	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	166000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	59000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	138000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4357000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21948000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4384000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-21941000	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	343000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2023	glow	Warrants Conversions Inducements WarrantsConversionsInducements	751000	usd
CY2022	glow	Warrants Conversions Inducements WarrantsConversionsInducements	0	usd
CY2023	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	25000	usd
CY2022	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5503000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21941000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.62
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-10.62
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5595000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5595000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2065000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2065000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	25497000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-21941000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	146000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	85000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3617000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4384000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	504000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5364000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	534000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	209000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	343000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	5501000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4384000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-21941000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	345000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1903000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-52000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	118000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	125000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	349000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	504000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	146000	usd
CY2023	glow	Forfeiture Of Unvested Stock Options ForfeitureOfUnvestedStockOptions	0	usd
CY2022	glow	Forfeiture Of Unvested Stock Options ForfeitureOfUnvestedStockOptions	85000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-3000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	483000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	61000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	259000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5133000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	179000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7367000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-43000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-316000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-406000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-432000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-484000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-615000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-28000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-69000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	27000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-75000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-170000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	115000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-392000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-614000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-219000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-503000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2993000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5934000	usd
CY2023	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	0	usd
CY2022	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	30000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5364000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	534000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5898000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our Consolidated Financial Statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the estimated credit losses and the inputs used in the fair value of equity based awards.</span></div>
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2905000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5915000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3085000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5990000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3085000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	20000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	7000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	31000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q4	us-gaap	Cash Cash	5490000	usd
CY2022Q4	us-gaap	Cash Cash	3085000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5990000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3085000	usd
CY2023	glow	New Operating Lease Agreement NewOperatingLeaseAgreement	0	usd
CY2022	glow	New Operating Lease Agreement NewOperatingLeaseAgreement	11000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	343000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	0	usd
CY2023	glow	Warrant Modification WarrantModification	25000	usd
CY2022	glow	Warrant Modification WarrantModification	0	usd
CY2023	glow	Stock Issued Share Based Compensation StockIssuedShareBasedCompensation	751000	usd
CY2022	glow	Stock Issued Share Based Compensation StockIssuedShareBasedCompensation	0	usd
CY2023	glow	Stock Issued Conversion Of Preferred Stock StockIssuedConversionOfPreferredStock	209000	usd
CY2022	glow	Stock Issued Conversion Of Preferred Stock StockIssuedConversionOfPreferredStock	0	usd
CY2023Q4	glow	Subsidiary Investee Ownership Percentageby Parent SubsidiaryInvesteeOwnershipPercentagebyParent	1
CY2022Q4	glow	Subsidiary Investee Ownership Percentageby Parent SubsidiaryInvesteeOwnershipPercentagebyParent	1
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5990000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3085000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	577000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	624000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	153000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	209000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	415000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-52000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	118000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	949000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div>Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and trade accounts receivable. We place our cash needed for operations in commercial checking accounts, and the majority of our cash is held in a money market fund. Commercial bank balances may from time to time exceed federal insurance limits. Deposits are insured by the Federal Deposit Insurance Corporation (the “FDIC”) in an amount up to $250,000 for any depositor, any deposit in excess of this insured amount could be lost.
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	604000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	142000	usd
CY2023	glow	Impairment Long Lived Asset Held For Use Net Of Gain Loss On Sale ImpairmentLongLivedAssetHeldForUseNetOfGainLossOnSale	3000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	259000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5133000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7367000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	179000	usd
CY2023Q4	glow	Lessee Operating Lease Number Of Right Of Use Assets LesseeOperatingLeaseNumberOfRightOfUseAssets	2	lease_asset
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	236000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	533000	usd
CY2022	us-gaap	Insurance Recoveries InsuranceRecoveries	50000	usd
CY2023	us-gaap	Insurance Recoveries InsuranceRecoveries	400000	usd
CY2022	glow	Inventory Write Down Net Of Insurance Proceeds InventoryWriteDownNetOfInsuranceProceeds	483000	usd
CY2023	glow	Inventory Write Down Net Of Insurance Proceeds InventoryWriteDownNetOfInsuranceProceeds	-400000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5990000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	500000	usd
CY2023Q4	glow	Working Capital WorkingCapital	5498000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4384000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-21941000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2993000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5934000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	19000	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5364000	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	534000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	930000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	1175000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	691000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	452000	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	342000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	316000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	75000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	131000	usd
CY2023Q4	glow	Tax Credit Receivable Current TaxCreditReceivableCurrent	0	usd
CY2022Q4	glow	Tax Credit Receivable Current TaxCreditReceivableCurrent	316000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	98000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	90000	usd
CY2023Q4	glow	Prepaid Software Licenses PrepaidSoftwareLicenses	70000	usd
CY2022Q4	glow	Prepaid Software Licenses PrepaidSoftwareLicenses	112000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	243000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	649000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2207000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	0	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2204000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3000	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	0	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	78000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	690000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	86000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	604000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	259000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	5133000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	345000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1825000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7367000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	448000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	707000	usd
CY2023Q4	glow	Deposits Current DepositsCurrent	118000	usd
CY2022Q4	glow	Deposits Current DepositsCurrent	128000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	104000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	57000	usd
CY2023Q4	glow	Accrued Sales Taxes And Regulatory Fees AccruedSalesTaxesAndRegulatoryFees	22000	usd
CY2022Q4	glow	Accrued Sales Taxes And Regulatory Fees AccruedSalesTaxesAndRegulatoryFees	59000	usd
CY2023Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	202000	usd
CY2022Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	0	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	136000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	123000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1038000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1074000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	214000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	502000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	140000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	142000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	219000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	236000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	17000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	0	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	17000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	659000	usd
CY2022	glow	Operating Lease Right Of Use Asset Additions OperatingLeaseRightOfUseAssetAdditions	11000	usd
CY2022	glow	Operating Lease Liability Additions OperatingLeaseLiabilityAdditions	11000	usd
CY2022	glow	Operating Lease Right Of Use Asset Amortization And Reductions OperatingLeaseRightOfUseAssetAmortizationAndReductions	349000	usd
CY2022	glow	Operating Lease Liability Amortizations Expense OperatingLeaseLiabilityAmortizationsExpense	503000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	179000	usd
CY2022	glow	Operating Lease Liability Impairment Loss OperatingLeaseLiabilityImpairmentLoss		usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	142000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	236000	usd
CY2023	glow	Operating Lease Right Of Use Asset Amortization And Reductions OperatingLeaseRightOfUseAssetAmortizationAndReductions	125000	usd
CY2023	glow	Operating Lease Liability Amortizations Expense OperatingLeaseLiabilityAmortizationsExpense	219000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16692124	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16684571	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	glow	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	667	shares
CY2023Q2	glow	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	1934	shares
CY2023Q2	glow	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	667	shares
CY2023Q2	glow	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	1934	shares
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.2792
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.2792
CY2023Q4	glow	Class Of Warrant Or Right Issued ClassOfWarrantOrRightIssued	4137850	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	343099	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	995.06
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	343099	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	66.34
CY2023	glow	Class Of Warrant Or Right Granted ClassOfWarrantOrRightGranted	4543626	shares
CY2023	glow	Class Of Warrant Or Right Granted Weighted Average Exercise Price ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice	1.71
CY2023	glow	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	746027	shares
CY2023	glow	Class Of Warrant Or Right Exercised Weighted Average Exercise Price ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice	0.78
CY2023	glow	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	2601	shares
CY2023	glow	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	76.93
CY2023	glow	Class Of Warrant Or Right Forfeited ClassOfWarrantOrRightForfeited	-247	shares
CY2023	glow	Class Of Warrant Or Right Forfeited Weighted Average Exercise Price ClassOfWarrantOrRightForfeitedWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4137850	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.73
CY2023Q4	glow	Preferred Stock Shares Designated PreferredStockSharesDesignated	1983250	shares
CY2022Q4	glow	Preferred Stock Shares Designated PreferredStockSharesDesignated	1983250	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1930	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1930	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1930	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1930	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.2792
CY2023Q4	us-gaap	Preferred Stock Convertible Conversion Price PreferredStockConvertibleConversionPrice	0.2792
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3336	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	6668	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	501	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.75
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27169	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	113.63
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7169	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	294.63
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2022	glow	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3332	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	97.56
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	501	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	410.18
CY2022	glow	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares	501	shares
CY2022	glow	Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice	410.18
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	48.75
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	16668	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	29.25
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	10000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	223.11
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	0	shares
CY2023	glow	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	3336	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	48.75
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	6668	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	285.89
CY2023	glow	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodNumberOfShares	6668	shares
CY2023	glow	Share Based Compensation Arrangement By Share Based Payment Award Options Expired Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredWeightedAverageExercisePrice	285.89
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	48.75
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6668	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	48.75
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	61000	usd
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4384000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-21941000	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	343000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	0	usd
CY2023	glow	Warrants Conversions Inducements WarrantsConversionsInducements	751000	usd
CY2022	glow	Warrants Conversions Inducements WarrantsConversionsInducements	0	usd
CY2023	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	25000	usd
CY2022	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	0	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5503000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21941000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5595000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2065000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.98
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-10.62
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3810000	usd
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	2899000	usd
CY2023	us-gaap	Gross Profit GrossProfit	911000	usd
CY2023	glow	Gross Profit Percentage GrossProfitPercentage	0.24
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	5406000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-4495000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	138000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4357000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4384000	usd
CY2023Q4	us-gaap	Assets Assets	6925000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5476000	usd
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	3930000	usd
CY2022	us-gaap	Gross Profit GrossProfit	1546000	usd
CY2022	glow	Gross Profit Percentage GrossProfitPercentage	0.282
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	23534000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-21988000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21948000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-21941000	usd
CY2022Q4	us-gaap	Assets Assets	5661000	usd
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Remeasurement1 ForeignCurrencyExchangeRateRemeasurement1	0.01
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3810000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5476000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4357000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-21948000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4357000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-21948000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	15000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-4000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	12000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-3000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	27000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-7000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-915000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4609000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	0	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Impairment Losses IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses	1547000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-58000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-375000	usd
CY2023	glow	Effective Income Tax Rate Reconciliation Operating Loss Carryforwards Expired Amount EffectiveIncomeTaxRateReconciliationOperatingLossCarryforwardsExpiredAmount	613000	usd
CY2022	glow	Effective Income Tax Rate Reconciliation Operating Loss Carryforwards Expired Amount EffectiveIncomeTaxRateReconciliationOperatingLossCarryforwardsExpiredAmount	76000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	385000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	16000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-112000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3273000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	114000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	65000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	27000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	131000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	147000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	36000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	129000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	56000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	420000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	4000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	116000	usd
CY2023Q4	glow	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	0	usd
CY2022Q4	glow	Deferred Tax Assets Goodwill DeferredTaxAssetsGoodwill	28000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	156000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	106000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	32000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	80000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	409000	usd
CY2023Q4	glow	Deferred Tax Assets Tax Deferred Expense Interest Expense DeferredTaxAssetsTaxDeferredExpenseInterestExpense	314000	usd
CY2022Q4	glow	Deferred Tax Assets Tax Deferred Expense Interest Expense DeferredTaxAssetsTaxDeferredExpenseInterestExpense	0	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2154000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2154000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	55000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	74000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	61000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	101000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38380000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38492000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38380000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	38492000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-112000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3273000	usd
CY2019	glow	Operating Loss Carryforwards Permanent Loss Of Tax Benefit Resulting From Ownership Change OperatingLossCarryforwardsPermanentLossOfTaxBenefitResultingFromOwnershipChange	30880000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2154000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2154000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	64000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	93000	usd

Files In Submission

Name	View Source	Status
0000746210-24-000009-index-headers.html	Edgar Link	pending
0000746210-24-000009-index.html	Edgar Link	pending
0000746210-24-000009.txt	Edgar Link	pending
0000746210-24-000009-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
glow-20231231.htm	Edgar Link	pending
glow-20231231.xsd	Edgar Link	pending
image_2.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oblg2023ex211.htm	Edgar Link	pending
oblg2023ex231.htm	Edgar Link	pending
oblg2023ex311.htm	Edgar Link	pending
oblg2023ex312.htm	Edgar Link	pending
oblg2023ex321.htm	Edgar Link	pending
oblg2023ex32conformedbylaws.htm	Edgar Link	pending
glow-20231231_cal.xml	Edgar Link	unprocessable
glow-20231231_def.xml	Edgar Link	unprocessable
glow-20231231_lab.xml	Edgar Link	unprocessable
glow-20231231_pre.xml	Edgar Link	unprocessable
glow-20231231_htm.xml	Edgar Link	completed
oblg2023ex419descriptionof.htm	Edgar Link	pending
oblg2023ex971clawbackpolicy.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OBLG
Oblong, Inc. Stock $oblg

2024 Q1 Form 10-K Financial Statement

#000074621024000009 Filed on March 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OBLG Oblong, Inc. Stock $oblg

2024 Q1 Form 10-K Financial Statement

#000074621024000009 Filed on March 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OBLG
Oblong, Inc. Stock $oblg